期刊文献+

估算肾小球滤过率与急性ST段抬高型心肌梗死患者心肌无复流的相关性研究 被引量:4

Relationship Between Estimated Glomerular Filtration Rate and Myocardial No-reflow in Patients With Acute ST-elevation Myocardial Infarction
下载PDF
导出
摘要 目的:探讨估算肾小球滤过率(eGFR)与急性ST段抬高型心肌梗死(STEMI)患者心肌无复流(MNR)的相关性。方法:收集2013-01至2015-06期间烟台毓璜顶医院因STEMI接受急诊经皮冠状动脉介入治疗(PCI)的患者461例,其中男373例,女88例,平均年龄(61.46±12.29)岁。PCI成功开通心外膜血管后仍有部分患者存在心肌灌注不足的表现,即心肌无复流(MNR)。MNR定义为心肌梗死溶栓治疗临床试验(TIMI)血流分级<3级或TIMI 3级且心肌呈色分级(MBG)≤2。461例患者中98例发生MNR(无复流组),363例成功复流(复流组)。根据MDRD(Modification of Diet in Renal Disease)公式计算eGFR。比较两组球囊扩张时间、病变长度变化。结果:461例患者中共计98例(21.26%)患者发生MNR。410例(88.94%)患者PCI术后冠状动脉血流达TIMI 3级(复流组363例,无复流组47例);334例(72.45%)患者MBG3级(复流组334例,无复流组0例),两组比较差异均有统计学意义(P<0.001)。与复流组相比,无复流组发病至球囊扩张时间较长(P<0.001),syntax评分较增加(P<0.001),病变长度较延长(P=0.017),差异均有统计学意义。多因素Logistic回归分析表明收缩压[比值比(OR):0.984,95%可信区间(CI):0.970~0.984,P=0.023]、左心室射血分数(OR:0.957,95%CI:0.913~0.987,P=0.031)、eGFR(OR:0.964,95%CI:0.950~0.964,P<0.001)、发病至球囊扩张时间(OR:1.004,95%CI:1.002~1.004,P=0.001)是MNR发生的独立危险因素。受试者工作特征(ROC)曲线显示eGFR[曲线下面积:0.801,95%CI:0.743~0.859,P<0.001;理想阈值74.78 ml/(min·1.73m^2),敏感性为73.7%,特异性为77.3%]可以较好的预测MNR发生。结论:eGFR降低与STEMI患者行急诊PCI术后MNR的发生密切相关。 Objective: To explore the relationship between estimated glomerular filtration rate(eGFR) and myocardial no-reflow(MNR) in patients with ST-segment elevation myocardial infarction(STEMI) after primary percutaneous coronary intervention(PCI).Methods: A total of 461 eligible STEMI patients treated by primary PCI in our hospital from 2013-01 to 2015-06 were enrolled including 373 male and 88 female with the mean age of(61.46±12.29) years. MNR was defined as TIMIgrade 3 or TIMI grade 3 with myocardial blush grades(MBG)≤2. The patients were divided into 2 groups: MNR group, n=98(21.26%) and Re-flow group, n=363. eGFR was calculated by MDRD(modification of diet in renal disease) equation. The balloon dilatation time and lesion length were compared between 2 groups.Results: There were 410(88.94%) patients reached post PCI TIMI grade 3 including 363 in Re-flow group and 47in MNR group; 334(72.45%) patients with MBG grade 3 including 334 in Re-flow group, 0 in MNR group, all P0.001. Compared with Re-flow group, MNR group had prolonged time form onset to balloon dilatation, P0.001, increased syntax score, P0.001 and extend length of lesion, P=0.017. Multi Logistic regression analysis showed that systolic blood pressure(OR=0.984, 95% CI 0.970-0.84, P =0.023), left ventricular ejection fraction(OR=0.957, 95% CI 0.913-0.987, P =0.031), eG FR(OR=0.964, 95% CI 0.950-0.964, P0.001), the time from onset to balloon dilatation(OR=1.004, 95% CI 1.002-1.004, P=0.001) were the independent risk factors for MNR occurrence. The area of ROC_(eGFR)=0.801,(95% CI 0.743-0.859, P0.001) and the optimal threshold=74.78 ml/(min·1.73m^2) with the sensitivity of 73.7% and specificity of 77.3% may better predict the incidence of MNR.Conclusion: Decreased eGFR was closely related to MNR occurrence in STEMI patients after primary PCI.
出处 《中国循环杂志》 CSCD 北大核心 2016年第11期1064-1068,共5页 Chinese Circulation Journal
基金 山东省自然科学基金联合专项(批准编号:ZR2014HL009)
关键词 肾小球滤过率 心肌梗死 无复流 Glomerular filtration rate Myocardial infarction No-reflow
  • 相关文献

参考文献3

二级参考文献29

  • 1De Zeeuw D. Renal disease: a common and a silent killer. Nat Clin Pract Cardiovasc Med ,2008,5 :$27-35.
  • 2Ritz E, McClellan WM. Overview:increased cardiovascular risk in patients with minor renal dysfunction:an emerging issue with far-reaching consequences. J Am Soc Nephrol,2004,15 :513-516.
  • 3Go AS, Chertow GM, Fan D,et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med ,2004,351 : 1296-1305.
  • 4Mann JF,Gerstein HC, Pogue J, et al. Cardiovascular risk in patients with early renal insufficiency: implications for the use of ACE inhibitors . Am J Cardiovasc Drugs ,2002,2 (3) :157-162.
  • 5Munster P, He J, Hamm L, et al. Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. J Am Soc Nephrol,2002,13:745-753.
  • 6Manjunath G,Tighiouart H,Ibrahim H,et al. Level of kidney function as a risk factor for atherosclerotic cardiovascular disease in the community. J Am Coll Cardiol,2003,41 ( 1 ) :47-55.
  • 7Sarnak MJ,Levey AS,Schoolwerth AC,et al. Kidney disease as a risk factor for factor for development of cardiovascular disease : a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation, 2003, 108: 2154- 2169.
  • 8Ridker PM, Cushman M ,Stampfer MT, et al. Inflammation, asprin and the risk of cardiovascular disease in apparently healthy men. N Engl J Med,1997,336(14) :973-979.
  • 9Cottone S,Lorito MC, Rieeobene R,et al. Oxidative stress,inflammation and cardiovascular disease in chronic renal failure. J Nephrol, 2008,21: 175-179.
  • 10Shah SV, Baliga R,Rajapurkar M,et al. Oxidants in chronic kidney disease. J Am Soc Nephrol,2007,18(1) :16-28.

共引文献76

同被引文献28

二级引证文献52

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部